Statement by the Royal Institute of Public Health and Hygiene and Society of Public Health on the 'Review of the Framework for Overseeing Developments in Biotechnology'
Public Health 1999 May; 113(3): 147-148
Showing items related by title, author, creator and subject.
The Human Genome Project: How Private Sector Developments Affect the Government Program [Hearing Charter; Statement of Dr. Ari Patrinos, Associate Director, Office of Biological and Environmental Research, Office of Energy Research, Department of Energy; Statement of Dr. J. Craig Venter, President and Director, The Institute for Genomic Research; Statement of Dr. Francis S. Collins, Director, National Human Genome Research Institute; Statement of Dr. David J. Galas, President and Chief Scientific Officer, Chiroscience R & D Inc.; Testimony of Dr. Maynard V. Olson] United States. Congress. House. Committee on Science. Subcommittee on Energy and Environment (1998-06-17)
Public Policy Statement on the Rights and Responsibilities of Health Care Professionals in the Use of Opioids for the Treatment of Pain: A Consensus Document From the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine Unknown author (American Academy of Pain Medicine; American Pain Society; American Society of Addiction Medicine, 2004-09)